Daito Pharmaceutical Co., Ltd. (TYO:4577)
Japan · Delayed Price · Currency is JPY 1,317.00
-4.00 (-0.30%)
Nov 13, 2026, 3:30 PM JST
Daito Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 37,218 | 34,664 | 29,536 | 34,043 | 33,086 | 37,154 | |
Market Cap Growth | 1.28% | 17.36% | -13.24% | 2.89% | -10.95% | -17.40% |
Enterprise Value | 44,041 | 43,017 | 37,736 | 37,799 | 34,956 | 37,065 |
Last Close Price | 1317.00 | 1202.00 | 953.97 | 1041.20 | 951.20 | 1055.36 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 12.08 | 10.97 | 15.48 | 10.33 | 9.19 | 7.96 |
Forward PE | 13.61 | 13.33 | 15.15 | 8.98 | 9.39 | 8.00 |
PS Ratio | 0.75 | 0.68 | 0.58 | 0.73 | 0.73 | 0.86 |
PB Ratio | 0.71 | 0.66 | 0.57 | 0.65 | 0.65 | 0.78 |
P/TBV Ratio | 0.73 | 0.68 | 0.57 | 0.66 | 0.66 | 0.79 |
P/FCF Ratio | 6.70 | 6.24 | - | - | - | - |
P/OCF Ratio | 3.97 | 3.70 | 5.01 | 6.57 | 7.96 | 8.50 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
EV/Sales Ratio | 0.89 | 0.85 | 0.75 | 0.81 | 0.78 | 0.85 |
EV/EBITDA Ratio | 5.61 | 5.36 | 5.43 | 5.00 | 3.85 | 3.75 |
EV/EBIT Ratio | 12.76 | 11.83 | 14.40 | 9.71 | 6.71 | 5.64 |
EV/FCF Ratio | 7.92 | 7.74 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Debt / Equity Ratio | 0.16 | 0.18 | 0.23 | 0.17 | 0.10 | 0.07 |
Debt / EBITDA Ratio | 1.09 | 1.16 | 1.71 | 1.15 | 0.55 | 0.35 |
Debt / FCF Ratio | - | 1.67 | - | - | - | - |
Net Debt / Equity Ratio | 0.13 | 0.16 | 0.19 | 0.12 | 0.03 | -0.02 |
Net Debt / EBITDA Ratio | 0.87 | 1.04 | 1.39 | 0.79 | 0.15 | -0.09 |
Net Debt / FCF Ratio | - | 1.50 | -10.85 | -5.77 | -1.00 | 3.63 |
Asset Turnover | 0.66 | 0.67 | 0.65 | 0.63 | 0.67 | 0.71 |
Inventory Turnover | 2.20 | 2.34 | 2.14 | 1.89 | 1.98 | 1.97 |
Quick Ratio | 1.27 | 1.42 | 1.32 | 1.05 | 1.38 | 1.46 |
Current Ratio | 2.64 | 2.62 | 2.45 | 2.24 | 2.64 | 2.70 |
Return on Equity (ROE) | 6.07% | 5.97% | 3.38% | 6.16% | 7.15% | 10.33% |
Return on Assets (ROA) | 2.78% | 3.00% | 2.10% | 3.28% | 4.81% | 6.69% |
Return on Invested Capital (ROIC) | 4.45% | 4.56% | 2.61% | 5.31% | 7.31% | 10.20% |
Return on Capital Employed (ROCE) | 5.80% | 6.10% | 4.30% | 6.60% | 9.50% | 12.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Earnings Yield | 8.28% | 9.12% | 6.46% | 9.68% | 10.88% | 12.56% |
FCF Yield | 14.94% | 16.04% | -3.02% | -3.05% | -4.08% | -0.69% |
Dividend Yield | 3.42% | 3.32% | 3.55% | 2.70% | 2.60% | 1.92% |
Payout Ratio | 38.97% | 35.40% | 52.31% | 27.53% | 25.86% | 14.14% |
Buyback Yield / Dilution | 4.12% | 3.31% | 3.06% | 0.86% | -3.38% | -1.94% |
Total Shareholder Return | 7.54% | 6.63% | 6.62% | 3.56% | -0.78% | -0.02% |